Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Corporate Update

22 Apr 2021 07:00

RNS Number : 2772W
Time Finance PLC
22 April 2021
 

22 April 2021

 

 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Corporate Update

 

Net Tangible Assets and Net Cash continue to grow. Arrears below pre-pandemic levels and forbearance down 90% from June 2020 peak

 

Time Finance plc, the AIM listed independent specialist finance provider, is pleased to announce the continued strengthening of its balance sheet with increasing Net Tangible Assets ("NTA") and further increases in its cash reserves. Additionally, the Group continues to be supported by its key funding partners, having recently negotiated renewals and funding increases across a number of facilities within its Asset and Loan divisions.

 

Robust Balance Sheet

 

Notwithstanding the wider macroeconomic environment, the Group's NTA continue to increase month on month. At 31 March 2021, unaudited NTA amounted to approximately £28.5m compared to £26.5m at 31 May 2020. Over the same period, the Group's focus on cash generation has continued to have a positive impact on liquidity with cash and cash equivalents of over £6m at 31 March 2021 compared to approximately £1.5m as at 31 May 2020. These healthy cash levels are vital for future lending growth.

 

The Group's lending book remains robust and resilient with pandemic-related forbearance having reduced from over £25m in June 2020 to under £2.5m at 31 March 2021. Most significantly, as at 31 March 2021, total arrears had fallen below the pre-Covid Levels of 28 February 2020 for the first time since the start of the pandemic.

 

Improved Funding Facilities

 

The Group has distinct funding lines for each of its three own-book lending divisions - Asset, Loan and Invoice Finance - and is pleased to report that it continues to enjoy significant support from all of its key funding partners. The Group has recently negotiated renewed and increased Block Discounting facilities for its Asset and Loan divisions totalling approximately £103.5m. These facilities sit alongside the Group's £42m back-to-back facility for the invoice finance division and the £25m medium-term loan note programme which is used primarily in the Loans division.

 

As has always been the case with the Group's asset and loan funding, these renewed borrowing facilities require the Group to fund between 10% and 20% of each deal from its own resources, with the funder providing the balance. The term lengths with funders are largely "matched" with the Group's own-book lending to UK SMEs. As such, the funding amortises over the duration of the lease or loan term, which is typically three years, and is not impacted by interest rate changes. This matching practice and fixed interest rate policy are key elements of the Group's risk management and governance policies.

 

James Roberts, Chief Financial Officer commented:

 

"I am pleased to report the further strengthening of the Group's commercial partnerships with a number of key funders, many of whom have been long-standing supporters of the Group. I believe this support is reflective of the regard the Group is held in by many parties within our industry. We now have sizeable funding facilities with significant headroom in place across all of our lending divisions. This affords both confidence and visibility in our funding capabilities to help achieve steady organic growth over the foreseeable future as we navigate a return to normality.

 

"I am also delighted that the value of deals in arrears is now below the level experienced before the pandemic began back in the first quarter of 2020. This is testament to both the resilience of our lending book and also the hard work and dedication of our credit and collections staff over the past twelve months."

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (as amended), which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018. Upon publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

 

 

Time Finance plc

 

Ed Rimmer, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

 

 

Cenkos Securities plc (NOMAD)

 

Max Hartley / Ben Jeynes (Nomad)

Julian Morse (Sales)

0207 397 8900

 

 

Walbrook PR

0207 933 8780

Paul Vann / Nicholas Johnson

07768 807631

 

paul.vann@walbrookpr.com

 

About Time Finance:

Time Finance's strategy is to focus on providing or arranging the finance UK SMEs require to fund their businesses and arranging vehicle and property-backed finance for consumers. The multi-product range for SMEs includes asset, vehicle, loan and invoice finance facilities. The Group operates a "hybrid" lending and broking model enabling it to optimize business levels through market and economic cycles

 

More information is available on the Company website www.timefinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDKBBNPBKKOQB
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.